Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract seeks to support ongoing canine cancer immunotherapy clinical trials that serve as important models for human cancer treatment due to the similarities in disease development and immune response between pet dogs and humans. The initiative will fund a network of five U01 awards, including one Network Coordinating Center that facilitates collaboration and conducts limited research, and four awards focusing on conducting canine immunotherapy clinical trials using single or combination treatment approaches. These trials aim to evaluate novel and existing immunotherapeutic agents, leveraging the translatability of canine cancer trials to human applications while also providing potential benefits to the canine patients involved. The funding opportunity consolidates previous related solicitations to streamline applications and continue progress in the field, particularly in developing canine immunotherapeutics and analytics such as immune checkpoint inhibitors. The National Cancer Institute intends to sustain and accelerate advancements in this area, enabling timely assessment of new drugs, combinations, dosing, and sequencing in canine patients. This effort reflects a dual benefit, improving treatment options for dogs while generating valuable insights for human cancer therapies. The contract is managed by the NIH and underscores its commitment to translational cancer research through a coordinated network-based approach.

General Info

Funding to support canine cancer immunotherapy trials via a collaborative NIH network for translational research.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
Office AddressUS

Full Description

Show more

The goal of this RFA is to continue to support canine cancer immunotherapy clinical trials as indicators of safe and effective cancer treatments in humans. Pet dog patients develop cancer spontaneously and the courses of disease and treatment responses are similar to those in humans. Canine clinical trial results are translatable to humans. The assessment of responses to immunotherapy in immune-intact animals with existing cancers, such as pet dog patients, is the only way to preclinically take into account all facets of the immune response to cancer and to therapies. Ethically, pet dogs can benefit from the clinical trials by receiving cutting-edge therapies supported by the NIH, while providing important data informative to human disease. The network supported by this U01 RFA will consist of five U01 awards. One U01 will serve as a multifunctional Network Coordinating Center that will not only facilitate coordination across the Canine Cancer Immunotherapy Network (K9CIN) but will also perform limited research to support the network. Four U01 recipients will conduct canine clinical trials using immunotherapeutic agents alone or in combination with other treatment modalities.

Through this reissue Notice of Funding Opportunity, the National Cancer Institute intends to continue to support canine immunotherapeutic development as the field continues to grow, in part because of NIH funding. In the last five years, canine immunotherapeutics such as immune checkpoint inhibitors have become available as have canine analytics, development of which were partially supported by NCI. The goal is to maintain the momentum for further development of canine analytics and therapeutics and the ability to evaluate novel and repurposed drugs, treatment combinations, and treatment dosing and sequencing in pet dogs in a timely fashion. This NOFO consolidates the prior U01 (RFA-CA-21-050) and U24 (RFA-CA-21-051) funding opportunities to streamline the application process for continued support to K9CIN. Applicants have the option of submitting either for the Network Coordinating Center with limited research focus or for conducting canine cancer immunotherapy clinical trials and correlative studies. These important canine cancer-related activities will provide a valuable opportunity for NIH support to benefit humans and dogs, at both ends of the leash.

Similar Contracts

NAICS: 541715
New
Federal
Consolidated Operations, Management, Engineering and Test (COMET) Follow-On ContractThe COMET Follow-On Contract supports a broad range of engineering, ground system development, spacecraft processing, and launch, landing, and recovery operations critical to NASA’s Exploration Systems Development programs including Exploration Ground Systems, the Space Launch System, and the Orion Multi-Purpose Crew Vehicle. It encompasses end-to-end capabilities for preparing and managing flight hardware at Kennedy Space Center, ensuring mission readiness for crewed and uncrewed deep space missions. The contract also extends its support to the International Space Station Program and the Launch Services Program, facilitating integrated operations across multiple high-priority NASA initiatives as well as commercial partnerships and collaborative ventures at the KSC facility. This contract is positioned as a forecast opportunity with a NAICS code of 541715, indicating its focus on research and development in the physical, engineering, and life sciences. Performance will occur at Kennedy Space Center, though the precise location is listed as TBD, reflecting the evolving nature of infrastructure planning. The Point of Contact for the opportunity is Nicholas Reinert, with Natalie Colvin serving as the Small Business Specialist, ensuring accessibility for diverse vendors. The contract is anticipated to be awarded following the posted forecast date of October 1, 2031, and will likely serve as a critical enabler for the next phase of U.S. space exploration activities involving sustainable lunar missions, deep space transit, and advanced ground infrastructure development.
Kennedy Space Center

POSTED

in over 5 years

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
FILMSS (Fully Integrated Lifecycle Mission Support Services) 3FILMSS 3 is a contract issued by NASA’s Ames Research Center to deliver comprehensive program, science, engineering, operations, and project management support across a broad spectrum of mission-critical initiatives. The contract encompasses biosciences flight development projects including mission implementation, instrument development, and technology advancement, as well as collaborative science programs such as astrobiology and virtual institutes. It also supports aeronautics research projects and various internal Ames offices, ensuring seamless integration of technical expertise and operational efficiency throughout the lifecycle of these efforts. Additionally, the contract provides specialized technical and professional services tailored to Ames Mission Support functions, enabling the center to advance its scientific and aeronautical objectives. The contract falls under NAICS code 541715 and is forecasted for release with a posted date of April 1, 2029. Primary point of contact for inquiries is Arlene D. Schwartz, with Robert E. Watts designated as the Small Business Specialist. Performance will be centered at Moffett Field, where the full scope of activities will be executed. Although the solicitation number and set-aside details are not specified, the contract is structured to facilitate robust support for NASA’s strategic priorities through integrated lifecycle services, with emphasis on collaboration, innovation, and mission readiness.
Ames Research Center

POSTED

in almost 3 years

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) IIThe Aeronautics and Spaceflight Systems Engineering Support Services II contract is designed to advance NASA’s mission by enabling cutting-edge research and technology development across aeronautics and spaceflight systems. It focuses on supporting scientific inquiry, engineering design, analysis, and development activities that push the boundaries of current capabilities, with particular emphasis on increasing the technology readiness level of emerging systems critical to future NASA missions. The scope includes the implementation of technology programs, test operations, systems analysis, conceptual design, and comprehensive program and project management support to ensure seamless integration and execution of complex aerospace initiatives. Work under this contract will be conducted primarily at NASA’s Ames Research Center in Moffett Field, with the primary focus on sustaining and enhancing the agency’s technical infrastructure and innovation pipeline. The contract supports a broad spectrum of technical disciplines essential to the development of next-generation aircraft and spacecraft, ensuring alignment with evolving mission objectives. Point of contact for inquiries is Mary E. Livingston, with Robert E. Watts serving as the Small Business Specialist, reflecting a commitment to broad participation. The contract falls under NAICS code 541715 and is forecasted for release in 2029, positioning it as a strategic vehicle for long-term R&D collaboration with industry and academic partners.
Ames Research Center

POSTED

in almost 3 years

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Marshall Engineering Technicians and Trades Support (METTS) IVThe METTS IV contract provides comprehensive engineering technician and trades support services to the Marshall Space Flight Center, specifically supporting the Engineering Directorate, Facilities Management Office, and various other programs and projects across the center. The contractor is responsible for delivering a broad range of technical services that span multiple disciplines and are critical to the successful execution of NASA’s mission-critical activities at Huntsville. This includes hands-on technical work, system maintenance, fabrication, testing, and other specialist trades, all performed in alignment with the detailed requirements outlined in the Performance Work Statement. The contractor must also ensure effective management and oversight to guarantee compliance with performance standards, schedule adherence, and quality control across all assigned tasks. All work is conducted at the Marshall Space Flight Center in Huntsville, and the contract is categorized under NAICS code 541715 for research and development in physical, engineering, and life sciences. Point of contact for program inquiries is Myron H. Tapscott, while Danielle R. Barnes serves as the Small Business Specialist, indicating an emphasis on small business participation. The forecasted posting date is October 1, 2027, signaling the anticipated timing for future solicitation activity.
Marshall Space Flight Center

POSTED

in over 1 year

DEADLINE

N/A
View Details